Research Article| Volume 20, ISSUE 5, P217-225, October 2006

Outcomes of Antipsychotic Drug Use in Community-Dwelling Elders With Dementia

      This study used administrative data from a large health care insurer in the southeast United States to describe the utilization pattern and health care outcomes of antipsychotic drug use in community-dwelling elders with dementia. Claims data from 959 unique cases were analyzed to address research aims. Overall, 27% of the sample was dispensed antipsychotic drugs, with the most prevalent type being atypical antipsychotic drugs. Individuals on any type of antipsychotic drug experienced more delirium, depression, hip fracture, falls, and syncope than those not on these drugs, even after controlling for age, sex, comorbidity, and number of other drugs prescribed. Implications for practice are discussed.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Archives of Psychiatric Nursing
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Alexopoulos G.S.
        • Streim J.
        • Carpenter D.
        • Docherty J.P.
        Using antipsychotic agents in older patients.
        Journal of Clinical Psychiatry. 2004; 65: 5-99
        • American Society of Health System Pharmacists
        AHFS drug information.
        ASHSP, Bethesda, MD2005
        • Baldwin R.C.
        • Gallagley A.
        • Gourlay M.
        • Jackson A.
        • Burns A.
        Prognosis of late life depression: A three-year cohort study of outcome and potential predictors.
        International Journal of Geriatric Psychiatry. 2006; 21: 57-63
        • Ballard C.G.
        • Thomas A.
        • Fossey J.
        • Lee L.
        • Jacoby R.
        • Lana M.M.
        • et al.
        A 3-month, randomized, placebo-controlled, neuroleptic discontinuation study in 100 people with dementia: The neuropsychiatric inventory median cutoff is a predictor of clinical outcome.
        Journal of Clinical Psychiatry. 2004; 65: 114-119
        • Buchanan R.J.
        • Wang S.
        • Ju H.
        • Graber D.
        Analyses of gender differences in profiles of nursing home residents with Alzheimer's disease.
        Gender Medicine. 2004; 1: 48-59
        • Centorrino F.
        • Albert M.J.
        • Drago-Ferrante G.
        • Koukopoulos A.E.
        • Berry J.M.
        • Baldessarini R.J.
        Delirium during clozapine treatment: Incidence and associated risk factors.
        Pharmacopsychiatry. 2003; 36: 156-160
        • Charlson M.E.
        • Pompei P.
        • Ales K.L.
        • MacKenzie C.R.
        A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation.
        Journal of Chronic Diseases. 1987; 40: 373-383
        • Cohen-Mansfield J.
        • Marx M.S.
        • Rosenthal A.S.
        A description of agitation in a nursing home.
        Journal of Gerontology, Series A Biological Sciences and Medical Sciences. 1989; 44A: M77-M84
        • Donaldson C.
        • Tarrier N.
        • Burns A.
        The impact of the symptoms of dementia on caregivers.
        British Journal of Psychiatry. 1997; 170: 62-68
        • Doody R.S.
        • Stevens J.C.
        • Beck C.
        • Dubinsky R.M.
        • Kaye J.A.
        • Gwyther L.
        • et al.
        Practice parameter: Management of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology.
        Neurology. 2001; 56: 1154-1166
        • Dyer C.B.
        • Pavlik V.N.
        • Murphy K.P.
        • Hyman D.J.
        The high prevalence of depression and dementia in elder abuse or neglect.
        Journal of the American Geriatric Society. 2000; 48: 205-208
        • Everitt D.E.
        • Fields D.R.
        • Soumerai S.S.
        • Avorn J.
        Resident behavior and staff distress in the nursing home.
        Journal of the American Geriatrics Society. 1991; 39: 792-798
        • Fialova D.
        • Topinkova E.
        • Gambassi G.
        • Finne-Soveri H.
        • Jonsson P.V.
        • Carpenter I.
        • et al.
        Potentially inappropriate medication use among elderly home care patients in Europe.
        Journal of the American Medical Association. 2005; 293: 1348-1358
        • Flaherty J.H.
        • Perry III, H.M.
        • Lynchard G.S.
        • Morley J.E.
        Polypharmacy and hospitalization among older home care patients.
        Journal of Gerontology. Series A Biological Sciences and Medical Sciences. 2000; 55: M554-M559
        • Food Drug Administration
        FDA issues public health advisory for antipsychotic drugs used for treatment of behavioral disorders in elderly patients.
        (Retrieved on February 6, 2006, from)
        • Galynker I.I.
        • Roane D.M.
        • Miner C.R.
        • Feinberg T.E.
        • Watts P.
        Negative symptoms in patients with Alzheimer's disease.
        American Journal of Geriatric Psychiatry. 1995; 3: 52-59
        • Gill S.S.
        • Rochon P.A.
        • Herrmann N.
        • Lee P.E.
        • Sykora K.
        • Gunraj N.
        • et al.
        Atypical antipsychotic drugs and risk of ischaemic stroke: Population based retrospective cohort study.
        British Medical Journal. 2005; 330: 445
        • Hebert L.E.
        • Beckett L.A.
        • Scherr P.A.
        • Evans D.A.
        Annual incidence of Alzheimer disease in the United States projected to the years 2000 through 2050.
        Alzheimer Disease and Associated Disorders. 2001; 15: 169-173
        • Jensen G.L.
        • Friedmann J.M.
        • Coleman C.D.
        • Smiciklas-Wright H.
        Screening for hospitalization and nutritional risks among community-dwelling older persons.
        American Journal of Clinical Nutrition. 2001; 74: 201-205
        • Katz I.R.
        • Rupnow M.
        • Kozma C.
        • Schneider L.
        Risperidone and falls in ambulatory nursing home residents with dementia and psychosis or agitation: Secondary analysis of a double-blind, placebo-controlled trial.
        American Journal of Geriatric Psychiatry. 2004; 12: 499-508
        • Kolanowski A.M.
        • Fick D.
        • Waller J.L.
        • Shea D.
        Spouses of persons with dementia: Their healthcare problems, utilization, and costs.
        Research in Nursing & Health. 2004; 27: 296-306
        • Lamb S.E.
        • Jorstad-Stein E.C.
        • Hauer K.
        • Becker C.
        Development of a common outcome data set for fall injury prevention trials: The prevention of falls network Europe consensus.
        Journal of the American Geriatrics Society. 2005; 53: 1618-1622
        • Lambert B.L.
        • Chou C.H.
        • Chang K.Y.
        • Tafesse E.
        • Carson W.
        Antipsychotic exposure and type 2 diabetes among patients with schizophrenia: A matched case–control study of California Medicaid claims.
        Pharmacoepidemiology and Drug Safety. 2005; 14: 417-425
        • Landi F.
        • Onder G.
        • Cesari M.
        • Barillaro C.
        • Russo A.
        • Bernabei R.
        Psychotropic medications and risk for falls among community-dwelling frail older people: An observational study.
        Journals of Gerontology. Series A, Biological Sciences and Medical Sciences. 2005; 60: 622-626
        • Liperoti R.
        • Mor V.
        • Lapane K.L.
        • Pedone C.
        • Gambassi G.
        • Bernabei R.
        The use of atypical antipsychotics in nursing homes.
        Journal of Clinical Psychiatry. 2003; 64: 1106-1112
        • Mayeux R.
        • Sano M.
        Treatment of Alzheimer's disease.
        New England Journal of Medicine. 1999; 341: 1670-1679
        • Mitchell J.
        • Mathews H.F.
        • Hunt L.M.
        • Cobb K.H.
        • Watson R.W.
        Mismanaging prescription medications among rural elders: The effects of socioeconomic status, health status, and medication profile indicators.
        Gerontologist. 2001; 41: 348-356
        • Murman D.L.
        • Chen Q.
        • Powell M.C.
        • Kuo S.B.
        • Bradley C.J.
        • Colenda C.C.
        The incremental direct costs associated with behavioral symptoms in AD.
        Neurology. 2002; 59: 1721-1729
        • Profenno L.A.
        • Tariot P.N.
        Pharmacologic management of agitation in Alzheimer's disease.
        Dementia and Geriatric Cognitive Disorders. 2004; 17: 65-77
        • Rapoport M.
        • Mamdani M.
        • Shulman K.I.
        • Herrmann N.
        • Rochon P.A.
        Antipsychotic use in the elderly: Shifting trends and increasing costs.
        International Journal of Geriatric Psychiatry. 2005; 20: 749-753
        • Sink K.M.
        • Holden K.F.
        • Yaffe K.
        Pharmacological treatment of neuropsychiatric symptoms of dementia: A review of the evidence.
        Journal of the American Medical Association. 2005; 293: 596-608
        • Starkstein S.E.
        • Jorge R.
        • Mizrahi R.
        • Robinson R.G.
        The construct of minor and major depression in Alzheimer's disease.
        American Journal of Psychiatry. 2005; 162: 2086-2093
        • Sultzer D.L.
        Psychosis and antipsychotic medications in Alzheimer's disease: Clinical management and research perspectives.
        Dementia and Geriatric Cognitive Disorders. 2004; 17: 78-90
        • Taggart L.
        • McCammon S.
        • Allred L.
        • Horner R.
        • May H.
        Effect of patient and physician gender on prescriptions for psychotropic drugs.
        Journal of Women's Health. 1993; 2: 353-357
        • Teri L.
        • Logsdon R.G.
        • Peskind E.
        • Raskind M.
        • Weiner M.
        • Tractenberg R.E.
        • et al.
        Treatment of agitation in Alzheimer's disease: An investigation of haloperidol, trazodone and behavior management techniques.
        Research and Practice in Alzheimer's Disease and Other Dementias. 2001; 5: 27-31
        • van Schoor N.M.
        • Smit J.H.
        • Twisk J.W.
        • Bouter L.M.
        • Lips P.
        Prevention of hip fractures by external hip protectors: a randomized.
        JAMA. 2003; 289: 1957-1962
        • Veehof L.J.
        • Stewart R.E.
        • Meyboom-de Jong B.
        • Haaijer-Ruskamp F.M.
        Adverse drug reactions and polypharmacy in the elderly in general practice.
        European Journal of Clinical Pharmacology. 1999; 55: 533-536
        • Wang P.S.
        • Schneeweiss S.
        • Avorn J.
        • Fischer M.A.
        • Mogun H.
        • Solomon D.H.
        • et al.
        Risk of death in elderly users of conventional vs atypical antipsychotic medications.
        New England Journal of Medicine. 2005; 353: 2335-2341
        • Wooltorton E.
        Olanzapine (Zyprexa): Increased incidence of cerebrovascular events in dementia trials.
        Canadian Medical Association Journal. 2004; 170: 1395